{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:01:24Z","timestamp":1794412884320,"version":"4.9.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.tem.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T18:36:51Z","timestamp":1422902211000},"page":"153-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Adipocytokines and hepatic fibrosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Neeraj K.","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Anania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2015.01.002_bib0005","first-page":"373295","article-title":"Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells","volume":"2014","author":"Duval","year":"2014","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.tem.2015.01.002_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CCO.0000000000000042","article-title":"Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer","volume":"26","author":"Lade","year":"2014","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.tem.2015.01.002_bib0015","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.01.002_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","article-title":"Cellular and molecular mechanisms in liver fibrogenesis","volume":"548","author":"Novo","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tem.2015.01.002_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-014-0057-8","article-title":"Strategies to detect hepatic myofibroblasts in liver cirrhosis of different etiologies","volume":"2","author":"Iwaisako","year":"2014","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.tem.2015.01.002_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2014.00167","article-title":"The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies","volume":"5","author":"Xu","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2015.01.002_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2014.05.001","article-title":"The portal fibroblast: not just a poor man's stellate cell","volume":"147","author":"Wells","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2015.01.002_bib0040","doi-asserted-by":"crossref","first-page":"869390","DOI":"10.1155\/2014\/869390","article-title":"Autophagy: a multifaceted partner in liver fibrosis","volume":"2014","author":"Mallat","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tem.2015.01.002_bib0045","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.tem.2015.01.002_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2014.00177","article-title":"Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools","volume":"5","author":"Meli","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2015.01.002_bib0055","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2015.01.002_bib0060","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.01.002_bib0065","doi-asserted-by":"crossref","first-page":"T71","DOI":"10.1530\/JOE-14-0258","article-title":"20 years of leptin: leptin in common obesity and associated disorders of metabolism","volume":"223","author":"DePaoli","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2015.01.002_bib0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4254\/wjh.v6.i8.570","article-title":"Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease","volume":"6","author":"Giby","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.tem.2015.01.002_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: a narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2015.01.002_bib0080","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1007\/s10620-011-1767-y","article-title":"Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease","volume":"56","author":"Nseir","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tem.2015.01.002_bib0085","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.3748\/wjg.v20.i42.15532","article-title":"Liver transplantation and non-alcoholic fatty liver disease","volume":"20","author":"Zezos","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tem.2015.01.002_bib0090","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/ijc.28105","article-title":"Obesity, adipokines and hepatocellular carcinoma","volume":"133","author":"Duan","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2015.01.002_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000329799","article-title":"Modulation of liver fibrosis by adipokines","volume":"29","author":"Marra","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.tem.2015.01.002_bib0100","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2174\/138161210791208857","article-title":"Role of adipocytokines in hepatic fibrosis","volume":"16","author":"Bertolani","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tem.2015.01.002_bib0105","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2174\/138161210791208884","article-title":"Leptin: the prototypic adipocytokine and its role in NAFLD","volume":"16","author":"Procaccini","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tem.2015.01.002_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5830\/CVJA-2010-083","article-title":"Once fat was fat and that was that: our changing perspectives on adipose tissue","volume":"22","author":"Ferris","year":"2011","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.tem.2015.01.002_bib0115","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1590\/S0004-27302010000800005","article-title":"Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy","volume":"54","author":"Paz-Filho","year":"2010","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.tem.2015.01.002_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","article-title":"Leptin in health and disease: facts and expectations at its twentieth anniversary","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2015.01.002_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2014.09.010","article-title":"Structure, production and signaling of leptin","volume":"64","author":"Munzberg","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2015.01.002_bib0130","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.bbadis.2014.10.001","article-title":"GATA binding protein 2 mediates leptin inhibition of PPARgamma1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation","volume":"1842","author":"Zhou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2015.01.002_bib0135","doi-asserted-by":"crossref","first-page":"36551","DOI":"10.1074\/jbc.M110.168542","article-title":"Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway","volume":"285","author":"Choi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.01.002_bib0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1194\/jlr.M045799","article-title":"Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-\/- lipodystrophic mice independent of hepatocyte leptin receptors","volume":"55","author":"Cortes","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.01.002_bib0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Prac. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.tem.2015.01.002_bib0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3727\/105221614X13919976902057","article-title":"Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development","volume":"16","author":"Wallace","year":"2014","journal-title":"Gene Expr."},{"key":"10.1016\/j.tem.2015.01.002_bib0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/BJ20102148","article-title":"Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis","volume":"440","author":"Handy","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2015.01.002_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.tem.2015.01.002_bib0165","article-title":"The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob\/ob mice through suppression of mitochondrial ROS\/RNS and inflammation","author":"Chung","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2015.01.002_bib0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2613.2011.00793.x","article-title":"Pathology of the liver in obese and diabetic ob\/ob and db\/db mice fed a standard or high-calorie diet","volume":"92","author":"Trak-Smayra","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.tem.2015.01.002_bib0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1042\/CS20110572","article-title":"Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis","volume":"123","author":"Yang","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.tem.2015.01.002_bib0180","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.25534","article-title":"Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats","volume":"55","author":"Yang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0185","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.bbadis.2014.10.001","article-title":"GATA binding protein 2 mediates leptin inhibition of PPARgamma1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation","volume":"1842","author":"Zhou","year":"2014","journal-title":"Biochim. Ebiophys. Acta"},{"key":"10.1016\/j.tem.2015.01.002_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-009-0027-3","article-title":"PI-3K\/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells","volume":"325","author":"Zhou","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tem.2015.01.002_bib0195","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2119\/molmed.2010.00105","article-title":"Potential role of leptin, adiponectin and three novel adipokines, visfatin, chemerin and vaspin, in chronic hepatitis","volume":"17","author":"Kukla","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.tem.2015.01.002_bib0200","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","author":"Seki","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2119\/molmed.2011.00243","article-title":"p38 mitogen-activated protein kinase and liver X receptor-alpha mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells","volume":"18","author":"Yan","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.tem.2015.01.002_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bph.12114","article-title":"The beta-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis","volume":"169","author":"Zhai","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2015.01.002_bib0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tcm.2014.08.001","article-title":"Adiponectin and insulin cross talk: the microvascular connection","volume":"24","author":"Zhao","year":"2014","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.tem.2015.01.002_bib0220","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.2174\/092986712803833254","article-title":"Adiponectin: key player in the adipose tissue-liver crosstalk","volume":"19","author":"Moschen","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tem.2015.01.002_bib0225","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tem.2015.01.002_bib0230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.trsl.2014.06.008","article-title":"Obesity and the liver: nonalcoholic fatty liver disease","volume":"164","author":"Koppe","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.tem.2015.01.002_bib0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2091-12-24","article-title":"Role of redox environment on the oligomerization of higher molecular weight adiponectin","volume":"12","author":"Briggs","year":"2011","journal-title":"BMC Biochem."},{"key":"10.1016\/j.tem.2015.01.002_bib0240","doi-asserted-by":"crossref","first-page":"e34952","DOI":"10.1371\/journal.pone.0034952","article-title":"Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes","volume":"7","author":"Misu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2015.01.002_bib0245","doi-asserted-by":"crossref","first-page":"549748","DOI":"10.1155\/2012\/549748","article-title":"Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus","volume":"2012","author":"Vrachnis","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.tem.2015.01.002_bib0250","doi-asserted-by":"crossref","first-page":"e110405","DOI":"10.1371\/journal.pone.0110405","article-title":"Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2015.01.002_bib0255","doi-asserted-by":"crossref","first-page":"e103793","DOI":"10.1371\/journal.pone.0103793","article-title":"AdipoR1\/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2015.01.002_bib0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2014.00069","article-title":"Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb","volume":"5","author":"Ahsan","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2015.01.002_bib0265","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1096\/fj.14-253229","article-title":"Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis","volume":"28","author":"Kumar","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2015.01.002_bib0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diff.2013.07.004","article-title":"From tissue mechanics to transcription factors","volume":"86","author":"Janmey","year":"2013","journal-title":"Differentiation"},{"key":"10.1016\/j.tem.2015.01.002_bib0275","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1038\/emm.2013.141","article-title":"The role of adiponectin in the production of IL-6, IL\u20138, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints","volume":"46","author":"Lee","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tem.2015.01.002_bib0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tem.2015.01.002_bib0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11481-014-9529-1","article-title":"Designer adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by hiv protease inhibitors","volume":"9","author":"Pepping","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.tem.2015.01.002_bib0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide\u2013based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.tem.2015.01.002_bib0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","volume":"60","author":"Granzow","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0300","doi-asserted-by":"crossref","DOI":"10.1002\/bab.1323","article-title":"Adiponectin attenuates Ang-induced TGFbeta1 production in human mesangial cells via an AMPK\u2013dependent pathway","author":"Tan","year":"2014","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.tem.2015.01.002_bib0305","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2015.01.002_bib0310","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1186\/ar4070","article-title":"The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy","volume":"14","author":"Fang","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tem.2015.01.002_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/ebm.2011.011255","article-title":"Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism","volume":"237","author":"Beier","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.tem.2015.01.002_bib0320","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tem.2015.01.002_bib0325","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","article-title":"TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tem.2015.01.002_bib0330","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.23049","article-title":"Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner","volume":"50","author":"Chanda","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0335","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0340","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tem.2015.01.002_bib0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2015.01.002_bib0350","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00335-014-9538-7","article-title":"The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis","volume":"25","author":"Cantley","year":"2014","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.tem.2015.01.002_bib0355","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.26227","article-title":"Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-gamma coactivator 1beta-dependent pathway","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0360","doi-asserted-by":"crossref","first-page":"170532","DOI":"10.1155\/2013\/170532","article-title":"Adipokines and hepatic insulin resistance","volume":"2013","author":"Li","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tem.2015.01.002_bib0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2047-783X-18-12","article-title":"Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity","volume":"18","author":"Al-Suhaimi","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.tem.2015.01.002_bib0370","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/hep.25742","article-title":"Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease","volume":"56","author":"Nobili","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0375","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3748\/wjg.v19.i28.4475","article-title":"Resistin mediates the hepatic stellate cell phenotype","volume":"19","author":"Dong","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tem.2015.01.002_bib0380","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-14-39","article-title":"The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis","volume":"14","author":"Shen","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.tem.2015.01.002_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2015.01.002_bib0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000348667","article-title":"Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity","volume":"6","author":"Krist","year":"2013","journal-title":"Obes. Facts"},{"key":"10.1016\/j.tem.2015.01.002_bib0395","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.22467","article-title":"The hepatic apelin system: a new therapeutic target for liver disease","volume":"48","author":"Principe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.01.002_bib0400","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tem.2015.01.002_bib0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-511X-12-11","article-title":"Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice","volume":"12","author":"Nan","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tem.2015.01.002_bib0410","first-page":"1992","article-title":"High glucose induces Rho\/ROCK-dependent visfatin and type I procollagen expression in rat primary cardiac fibroblasts","volume":"10","author":"Yang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tem.2015.01.002_bib0415","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2015.01.002_bib0420","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-13-0112","article-title":"Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease","volume":"169","author":"Docke","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2015.01.002_bib0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/psc.2621","article-title":"Vaspin (serpinA12) in obesity, insulin resistance, and inflammation","volume":"20","author":"Heiker","year":"2014","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.tem.2015.01.002_bib0430","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease","volume":"34","author":"Byrne","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2015.01.002_bib0435","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MCO.0b013e32832c7819","article-title":"The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis","volume":"12","author":"Lanthier","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.tem.2015.01.002_bib0440","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.23405","article-title":"Portal fibroblasts: underappreciated mediators of biliary fibrosis","volume":"51","author":"Dranoff","year":"2010","journal-title":"Hepatology"},{"issue":"Suppl 1.","key":"10.1016\/j.tem.2015.01.002_bib0445","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1755-1536-5-S1-S17","article-title":"Origin of myofibroblasts in liver fibrosis","volume":"5","author":"Brenner","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"Suppl. 2","key":"10.1016\/j.tem.2015.01.002_bib0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1746.2011.07002.x","article-title":"What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis","volume":"27","author":"Iwaisako","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2015.01.002_bib0455","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.tem.2015.01.002_bib0460","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis \u2013 current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327601500003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327601500003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T10:29:42Z","timestamp":1566296982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327601500003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S104327601500003X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2015.01.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipocytokines and hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}